News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
MarketBeat Market update
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Mountain Crest Acquisition 6 Corp. (MCAH), a SPAC, reported a net income of $348,644 for Q2 2026, primarily from interest on trust assets and a gain from the expiration of an over-allotment option. Despite this income, the company disclosed substantial doubt about its ability …
Cresud S.A.C.I.F. y A. (CRESY) announced it will make the fifth installment of interest and capital amortization on its Series XLV Fixed Rate Notes on August 24, 2026. The company will pay the full outstanding principal of USD 10,199,068, along with USD 204,540.21 in …
Harraden Circle Investments, LLC and Frederick V. Fortmiller, Jr. have reported a beneficial ownership of 1,809,472 Class A shares of FutureCrest Acquisition Corp. (FCRS), which represents 6.29% of the total class. This disclosure, made via an amended SCHEDULE 13G/A filing, indicates shared voting and …
Balyasny Asset Management L.P. and its affiliated entities have reported a 6.03% beneficial ownership stake in Crescent Biopharma, Inc., totaling 1,662,917 shares of Class A common stock. This ownership is primarily held through Atlas Private Holdings (Cayman) Ltd. and Atlas Diversified Master Fund, Ltd. …
Cresud S.A.C.I.F. y A. (NASDAQ:CRESY) Director Fernando Adrian Elsztain sold 10,000 shares of the company's stock for $10,600 on August 12th, reducing his position by 1.55%. This sale is part of a pattern of insider selling, with Elsztain having sold a total of 109,385 …
Oppenheimer has lowered its price target for Crescent Capital BDC (CCAP) to $14 from $16, while keeping a "Perform" rating on the stock. This adjustment comes shortly after B. Riley also revised its price target for CCAP to $12.50 from $13.50, maintaining a "Neutral" …
Crescent Capital BDC, Inc. (NASDAQ:CCAP) has received a consensus "Hold" rating from analysts, with an average 12-month price target of $13.30, despite recent target reductions from several firms. The company's latest quarterly earnings of $0.36 per share missed analyst estimates, and its shares have …
LADENBURG THALM/SH SH has lowered its price target for Crescent Capital BDC (NASDAQ:CCAP) from $15.00 to $14.00, while maintaining a "buy" rating. This adjustment follows a quarter where Crescent Capital BDC missed earnings and revenue expectations, reporting EPS of $0.36 against a $0.37 consensus …
Wells Fargo & Company has lowered its price target for Crescent Capital BDC (NASDAQ:CCAP) to $11.00 from $12.00, maintaining an "equal weight" rating. This implies a potential downside of 3.85% from the current share price, with the company currently holding a "Hold" consensus rating …
B. Riley has adjusted its price target for Crescent Capital BDC (CCAP) to $12.50 from the previous $13.50, while simultaneously maintaining a "Neutral" rating on the stock. This update comes as part of ongoing analyst recommendations for the company. Crescent Capital BDC focuses on …
This article provides the slide deck published by Crescent Capital BDC, Inc. in conjunction with their Q2 2026 earnings call. The company reported an EPS of $0.36, missing by $0.01, and revenue of $36.32M, a 15.51% year-over-year decrease, missing by $793.60K. The content focuses …
Crescent Capital BDC (CCAP) reported a slight miss on Q2 2026 net investment income and revenue, with NII at $0.36 per share against an estimate of $0.3667 and revenue at $36.32 million against a $37.33 million forecast. The company's net asset value (NAV) declined …
The Top 5 Analyst Questions From Crescent Energy's Q2 Earnings Call Crescent Energy's second quarter results reflected strong operational execution and meaningful improvements across its core basins. Management attributed the outperformance to higher oil production, significant cost reductions, and enhanced free cash flow generation, …
Crescent Capital BDC (NASDAQ:CCAP) reported Q2 2026 results, revealing a permanent reduction in management and incentive fees to enhance shareholder returns and dividend coverage, despite a continued decline in Net Asset Value (NAV) for the eighth consecutive quarter. The company posted net investment income …
Silvercrest Asset Management Group (NASDAQ:SAMG) saw its share price fall below its 200-day moving average, trading as low as $9.88. Despite this, analysts have a consensus "Hold" rating on the stock after upgrades from Zacks Research, Weiss Ratings, and Wall Street Zen. The company …
The article provides a Q2 earnings snapshot for Crescent Capital BDC but contains no actual financial details or specific results. The body of the article is empty, suggesting the content was not fully loaded or captured.
Crescent Capital BDC, Inc. (NASDAQ:CCAP) has declared a quarterly dividend of $0.34 per share, to be paid on October 15th to shareholders of record on September 30th. This translates to an annualized dividend yield of 11.6%. While the current dividend payout ratio is 79.1% …
Crescent Capital BDC (NASDAQ: CCAP) reported a net loss of $(0.09) per share for Q2 2026, alongside net investment income of $0.36 per share. The company's net asset value declined to $17.82 per share. Crescent BDC declared a regular cash dividend of $0.34 per …
Crescent Capital BDC, Inc. filed a Current Report on Form 8-K on August 10, 2026, to announce its financial results for the quarter that ended on June 30, 2026. The full content of the announcement requires users to log in, create an account, or …
Search by ticker symbol or company name and select a result to open its chart.